Radioactive main group and rare earth metals for imaging and therapy

TI Kostelnik, C Orvig - Chemical reviews, 2018 - ACS Publications
Radiometals possess an exceptional breadth of decay properties and have been applied to
medicine with great success for several decades. The majority of current clinical use …

Recommendations for management of patients with neuroendocrine liver metastases

A Frilling, IM Modlin, M Kidd, C Russell… - The lancet …, 2014 - thelancet.com
Many management strategies exist for neuroendocrine liver metastases. These strategies
range from surgery to ablation with various interventional radiology procedures, and include …

Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and …

SM Sadowski, V Neychev, C Millo, J Shih… - Journal of Clinical …, 2016 - ascopubs.org
Purpose Gastro-entero-pancreatic neuroendocrine tumors (GEPNETs) are increasing in
incidence, and accurate staging is important for selecting the appropriate treatment. 68Ga …

[HTML][HTML] Prospective of 68Ga-radiopharmaceutical development

I Velikyan - Theranostics, 2014 - ncbi.nlm.nih.gov
Abstract Positron Emission Tomography (PET) experienced accelerated development and
has become an established method for medical research and clinical routine diagnostics on …

Head-to-head comparison of 64Cu-DOTATATE and 68Ga-DOTATOC PET/CT: a prospective study of 59 patients with neuroendocrine tumors

CB Johnbeck, U Knigge, A Loft… - Journal of Nuclear …, 2017 - Soc Nuclear Med
Somatostatin receptor imaging is a valuable tool in the diagnosis, follow-up, and treatment
planning of neuroendocrine tumor (NET). PET-based tracers using 68Ga as the radioisotope …

Clinical applications of Gallium-68

SR Banerjee, MG Pomper - Applied Radiation and Isotopes, 2013 - Elsevier
Gallium-68 is a positron-emitting radioisotope that is produced from a 68Ge/68Ga generator.
As such it is conveniently used, decoupling radiopharmacies from the need for a cyclotron …

Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta …

G Treglia, P Castaldi, G Rindi, A Giordano, V Rufini - Endocrine, 2012 - Springer
Abstract Gallium-68 somatostatin receptor (SMSR) positron emission tomography (PET) and
positron emission tomography/computed tomography (PET/CT) are valuable diagnostic …

Somatostatin receptor PET/CT in neuroendocrine tumours: update on systematic review and meta-analysis

H Geijer, LH Breimer - European journal of nuclear medicine and …, 2013 - Springer
Purpose Neuroendocrine tumours (NET) are uncommon and may be localized in many
different places in the body. Traditional imaging has mainly been performed with CT and …

PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literature

CB Johnbeck, U Knigge, A Kjær - Future oncology, 2014 - Taylor & Francis
Neuroendocrine tumors have shown rising incidence mainly due to higher clinical
awareness and better diagnostic tools over the last 30 years. Functional imaging of …

Quantitative and qualitative intrapatient comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: net uptake rate for accurate quantification

I Velikyan, A Sundin, J Sörensen… - Journal of Nuclear …, 2014 - Soc Nuclear Med
Quantitative imaging and dosimetry are crucial for individualized treatment during peptide
receptor radionuclide therapy (PRRT). 177Lu-DOTATATE and 68Ga-DOTATOC/68Ga …